main image

todai

Akamon(University of Tokyo HP)

  • Clinic

  • Research

  • Publications

Dr.med. Sabine Neugebauer-Baba

Clinic

 

State examination
Approval
Recognition as an internist
Recognition as an angiologist
(vascular specialist)

1987 –1993

Year 1
Year 2
Year 3
Year 4
Year 5
Year 6

5th May 1987
2nd June 1987
Januar 1997
September 2004

Medical University of Lübeck (MUZL),
Internal Medicine Clinic
Nephrology (kidney medicine) and rheumatology
Hemodialysis, emergency services
Intensive care medicine, vascular outpatient clinic, endocrinology
Gastroenterology (gastrointestinal diseases)
Oncology and hematology (tumor and blood diseases)
Angiology and cardiology (vascular and heart diseases)

main image

 

01/1993 – 12/1999

University of Tokyo
Postdoctorial Fellow Genetic research on microangiopathic complications of diabetes. PhD Degree

 

01/2000 – 06/2002

Fukushima Medical University,
Treatment and training of diabetics

 

07/2002 – 11/2004

Dominikus Hospital Vascular Center, Düsseldorf
Treatment of patients with arteriosclerosis, such as smoker's leg and stroke

  2005 - Praxis.med. Neugebauer-Baba
  2010 - Opening of the private medical center with Tsuneharu Baba MD. PhD,
Prinzenallee 19, 40549 Düsseldorf for preventive examinationsmain image
  2014 - Academic teaching practice at the Heinrich Heine University Düsseldorf
Training of students and Authorization to continue training as a specialist in general medicine (for 2 years)
     

 


Dr.med. Sabine Neugebauer-Baba

Research

  Doktorate 08th May 1989 Medical University of Lübeck

 

Title

Development of a test strip for the detection of thyroid autoantibodies using the dot immunoassay with specially selected antigens
(Dealing with the early detection of thyroid diseases)

 

  PhD 30th März 2001 at University of Tokyo, Tokyo, Japan

 

Title

Genetic predisposition of type 2 diabetics to diabetic nephropathy and retinopathy: search for genetic markers
(Dealing with the early detection and treatment of circulatory disorders in diabetics)

 

 

Diabetes Research

1989 – 1992
1993 – 1994
1995 – 2001

Medical University of Lübeck
International Medical Center and
University of Tokyo, Tokyo, Japan

 

 

Research topics

Insulin receptor signal processing, molecular biological changes and genetic background of diabetic micro- and macrovascular complications, insulin resistance and hypertension

 

 

 

Research awards

Foreign Student Research Award from the University of Tokyo
11.03.1999 and 12.09.2000

 

 

Scholarships

Grants in Aid of the Japanese Society for Health and Anti-Aging (1993)

EU scholarship for the science and technology program in Japan (1995-1997)

 

 

Memberships
Academic
Societies

European Association of Study of Diabetes (EASD)
European Diabetic Nephropathy Study Group (EDNSG)
European Study Group of Diabetes and Hypertension
Japanese Diabetes Association
Association of German Internists

 

 


Dr.med. Sabine Neugebauer-Baba

International

  1. Neugebauer S. Development of a test strip with specially selected antigens for the detection of thyroid autoantibodies and thyroglobulin using the dot immunoassay. Dissertation, 1989
  2. Wenzel BE, Neugebauer S, Schultek T. Detection of thyroid auto-antibodies and of thyroglobulin with a new dot-ELISA method. Porceedings of the International Meeting on thyroid function and dysfunction: modern concepts. Pisa, October 2-4, 1985, pp 161-166
  3. Neugebauer S, Rob PM, Schulz E. Preclinical and clinical first aid for acute kidney failure (ANV). Lübeck Emergency Symposium 1989, R18
  4. Klein HH, Kowalewski B, Kotzke G, Drenckhan M, Neugebauer S, Matthaei S, Kotzke G. Decreased insulin effect on the activation of insulin receptor kinase in intact mononuclear cells from patients with non-insulin-dependent diabetes mellitus. Diabetes 42:883-890, 1993
  5. Baba T, Neugebauer S. The link between insulin resistance and hypertension: effect of antihypertensive and hypolipidaemic drugs on insulin sensitivity. Drugs 47:383-404, 1994
  6. Neugebauer S, Baba T, Watanabe T, Ishizaki T, Kurokawa K. The N-acetyltransferase (NAT) gene: an early risk marker for diabetic nephropa thy in Japanese Type 2 diabetic patients? Diabetic Med 11:783-788, 1994
  7. Baba T, Neugebauer S, Watanabe T. Current Understanding in the Link between Hypertension and Diabetic Nephropathy and Up-to-date Pharmacological Management. Drugs 54 (2):197-234, 1997
  8. Neugebauer S, Baba T, Kurokawa K, Watanabe T. Defective Homocysteine metabolism as a risk factor for diabetic retinopathy. Lancet 349:473-474, 1997
  9. Neugebauer S, Baba T, Watanabe T. Inherited disorder of the homocysteine metabolism: A risk factor for end-stage diabetic nephropathy. Therapeutic Research Vol 19, 1998
  10. Baba T, Drenckhan M, Neugebauer S, Klein H. Effect of angiotensin II and bradykinin on insulin-stimulated tyrosine kinase activity of insulin receptor. Diabetologia :741-742, 1998
  11. Neugebauer S, Baba T, Watanabe T. Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in NIDDM patients. Lancet 352:454, 1998
  12. Neugebauer S, Baba T, Watanabe T. Nitric oxide synthase gene polymorphism is associated with an increased risk for progression to diabetic nephropathy in Type 2 Diabetes. Diabetes 49:500-503, 2000
  13. Protein and gene procedures in: Laboratory techniques in renal cell and molecular biology, Editor Tomino Y, Karger, 2000
  14. S. Neugebauer, L. Tarnow, C. Stehouwer, T. Teerlink, T. Baba, T. Watanabe, H.-H. Parving. Total plasma homocysteine as determinant for hypertension: Missing link between moderate hyperhomocysteinemia and cardiovascular disease in Type I diabetic patients? Diabetologia 45:1315-1324, 2002